Eredene Capital Makes Partial Exit From Sattva CFS
TEAM VCCDebut exit for the AIM-listed investor, with returns of 5.9x; stake sale will bring down Eredene’s holding to 39%.
TOP HEADLINES
Pfizer, Teva Pharma & PE Firms Eye Micro Labs Buyout
SHRIJA AGRAWAL
Co might be eyeing a premium valuation due to its presence in the branded generics biz which commands higher margins.
Rupee At Two-and-a-half Month High
Re touched two-and-a-half-month high on Friday, aided by firm local shares, as demand for riskier assets was spurred by hopes that Greece would reach an agreement on debt restructuring. At 10.15 am, the rupee was at 49.72/73 per dollar, after touching 49.65, its highest since Nov 9.
Photo Credit: IndiaTodayImages.comMORE HEADLINES
IN CONVERSATION
Hybrid Model, Convergence To Gain Traction In E-com: Smile Group CEO
Smile Group is also keen to invest in its own ventures but does not target pure VC play, says founder & CEO Harish Bahl.
By NANDANA DAS
E-com Valuations Becoming Reasonable: MD, Helion Venture Partners
Kanwaljit Singh, co-founder & senior MD, discusses how e-com is stabilising & valuations are getting attuned to market.
By ANIL DAS
